HCA Healthcare Inc (HCA) Insider Michael S. Cuffe Sells 5,196 Shares of Stock

HCA Healthcare Inc (NYSE:HCA) insider Michael S. Cuffe sold 5,196 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total value of $709,357.92. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

HCA stock traded down $1.25 during midday trading on Friday, hitting $134.44. The stock had a trading volume of 2,084,314 shares, compared to its average volume of 2,122,171. The stock has a market cap of $46.21 billion, a price-to-earnings ratio of 20.40, a PEG ratio of 1.17 and a beta of 0.48. HCA Healthcare Inc has a 52-week low of $74.26 and a 52-week high of $141.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.13 earnings per share. As a group, equities research analysts predict that HCA Healthcare Inc will post 9.34 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be paid a $0.35 dividend. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 annualized dividend and a yield of 1.04%. HCA Healthcare’s payout ratio is 21.24%.

A number of brokerages recently commented on HCA. Credit Suisse Group upped their target price on HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a report on Thursday. SunTrust Banks upped their target price on HCA Healthcare to $145.00 and gave the company a “buy” rating in a report on Thursday, July 26th. Jefferies Financial Group upped their target price on HCA Healthcare from $155.00 to $158.00 and gave the company a “buy” rating in a report on Wednesday. ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. Finally, Barclays began coverage on HCA Healthcare in a report on Tuesday, August 14th. They set an “overweight” rating and a $150.00 target price for the company. Two research analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $141.26.

A number of hedge funds have recently modified their holdings of the stock. FMR LLC grew its stake in HCA Healthcare by 54.9% in the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after purchasing an additional 1,944,961 shares during the period. LSV Asset Management grew its stake in HCA Healthcare by 9.2% in the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after purchasing an additional 457,752 shares during the period. Northern Trust Corp grew its stake in HCA Healthcare by 4.2% in the second quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock worth $355,023,000 after purchasing an additional 138,135 shares during the period. Massachusetts Financial Services Co. MA grew its stake in HCA Healthcare by 98.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock worth $245,925,000 after purchasing an additional 876,226 shares during the period. Finally, Millennium Management LLC grew its stake in HCA Healthcare by 32.3% in the second quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after purchasing an additional 414,877 shares during the period. 70.48% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What is a stock split?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply